These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19222741)

  • 21. CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?
    Melamed ML; Buttar RS; Coco M
    Adv Chronic Kidney Dis; 2016 Jul; 23(4):262-9. PubMed ID: 27324680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consequences of the implementation of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease in a population of patients on chronic hemodialysis.
    Arenas MD; Alvarez-Ude F; Torregrosa V; Gil MT; Carretón MA; Moledous A; Nuñez C; Devesa R; Albiach B
    J Nephrol; 2007; 20(4):453-61. PubMed ID: 17879212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [How to manage mineral metabolism disorders in renal failure].
    Jean G
    Presse Med; 2011 Nov; 40(11):1043-52. PubMed ID: 21885239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters.
    Roetker NS; Peng Y; Ashfaq A; Gilbertson DT; Wetmore JB
    Am J Nephrol; 2019; 49(3):225-232. PubMed ID: 30820015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention and treatment of renal osteodystrophy in children with chronic renal insufficiency and end-stage renal disease.
    Sanchez CP
    Semin Nephrol; 2001 Sep; 21(5):441-50. PubMed ID: 11559885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends and consequences of mineral bone disorder in haemodialysis patients: lessons from The Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Blayney MJ; Tentori F
    J Ren Care; 2009 Mar; 35 Suppl 1():7-13. PubMed ID: 19222725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complexities of renal bone disease. 3.
    Markauskas I
    Nephrol News Issues; 2001 Jul; 15(8):41-3. PubMed ID: 12099228
    [No Abstract]   [Full Text] [Related]  

  • 29. Implications for nutrition practice in the mineral-bone disorder of chronic kidney disease.
    Moore LW
    Nutr Clin Pract; 2011 Aug; 26(4):391-400. PubMed ID: 21775636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Parathyroid and bone. Management of parathyroid function and evaluation of bone metabolism in hemodialysis patients].
    Goto S; Fukagawa M
    Clin Calcium; 2007 Dec; 17(12):1830-4. PubMed ID: 18057657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influences of method of calcium correction and the timing of blood collection on application of the K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Japan.
    Yokoyama K; Katoh N; Kasai K; Kubo H; Murai S; Shoji R; Imamura N; Saika S; Yumita S; Ishida M; Takasu S; Kono T; Yoshida Y; Wakabayashi T; Kimua Y; Hosoya T
    Ther Apher Dial; 2006 Jun; 10(3):257-61. PubMed ID: 16817790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review.
    Sigrist MK; Chiarelli G; Lim L; Levin A
    J Ren Care; 2009 Mar; 35 Suppl 1():71-8. PubMed ID: 19222735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of renal osteopathy in patients with chronic dialysis].
    Kiss D; Brunner FP
    Schweiz Med Wochenschr; 1996 Oct; 126(42):1792-8. PubMed ID: 8966512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adynamic bone and chronic renal failure: an overview.
    Cannata Andía JB
    Am J Med Sci; 2000 Aug; 320(2):81-4. PubMed ID: 10981480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].
    Hoshino J; Ubara Y; Takaichi K
    Clin Calcium; 2004 May; 14(5):731-7. PubMed ID: 15577034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient Education. Bone disease: preparing for your parathyroidectomy.
    McCall E; Keinholz M
    J Ren Nutr; 2013 Sep; 23(5):e101-2. PubMed ID: 23973100
    [No Abstract]   [Full Text] [Related]  

  • 38. Phosphate, Microbiota and CKD.
    Favero C; Carriazo S; Cuarental L; Fernandez-Prado R; Gomá-Garcés E; Perez-Gomez MV; Ortiz A; Fernandez-Fernandez B; Sanchez-Niño MD
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm.
    Rastogi A; Bhatt N; Rossetti S; Beto J
    J Ren Nutr; 2021 Jan; 31(1):21-34. PubMed ID: 32386937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of uremic osteodystrophy.
    Agus ZS; Goldberg M
    Radiol Clin North Am; 1972 Dec; 10(3):545-56. PubMed ID: 4566892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.